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Abstract
Background. Based on international statistics, the incidence of Infl ammatory Bowel Disease (IBD) is about 
2.2-14.3 cases per 100.000 people per year for Ulcerative Colitis (UC). In Indonesia there is no epidemiological 
study of IBD. To assess the degree of severity associated with the ulcerative colitis disease can be used a variety 
of tools, including the Truelove Witts score which has sensitivity and specifi city that high enough for UC in the 
phase of active disease. Interleukin-6 (IL-6) is a pro-infl ammatory cytokine that plays a very important role in 
self-defense mechanism and acts as an acute phase protein. Serum levels of IL-6 and increased expression in the 
colonic mucosa of active IBD patients indicate the level of IBD disease activity.
Aims. Th e aim of the study was to determine the relationship between Interleukin-6 expression (IL-6) and 
the severity of UC disease using Truelove Witts classifi cation.
Methods. Th is study used a cross sectional method that analyzed the relationship between IL-6 expression 
and UC weighing based on Truelove Witts classifi cation using colon tissue biopsy results from UC patients 
who met inclusion and exclusion criteria.
Results. Th ere were 26 subjects studied and performed an endoscopic analysis and anatomical pathology. 
Mean age of research subjects were 52.73 + 11.11 years with men's favored subjects (n = 15). Subjects were 
severe UC 16 (61.5%), moderate 7 (26.9%) and mild 3 (11.5%). More male subjects in mild UC, 12 vs. 3 
and more female subjects in moderate-severe UC, 4 vs. 7 (p 0.032). Signifi cant diff erences in IL-6 expression 
in defecation were > 4 times/day, IL-6 300 (285-400) versus defecation < 4 times/day, IL-6 295 (212.1-340) 
p 0.039. Signifi cant diff erence in IL-6 expression between mild UC 295 (212.1-340) with moderate- severe 
UC 301.66 (235.57-400) with p value 0.032.
Conclusion. IL-6 expression in moderate-severe UC subjects were higher than mild UC subjects based on 
Truelove Witts criteria.
Keywords:  Infl ammatory Bowel Disease,  Ulcerative Colitis,  Truelove Witts classifi cation,  Interleukin-6.
Abstrak
Latar belakang. Berdasarkan statistik internasional, insiden Infl amatory Bowel Disease (IBD) sekitar 2,2-14,3 
kasus per 100.000 orang per tahun untuk untuk kolitis ulseratif (KU). Di Indonesia belum ada studi epidemiologi 
tentang IBD. Untuk menilai derajat keparahan yang berhubungan dengan fase penyakit kolitis ulseratif dapat 
digunakan berbagai perasat, diantaranya adalah skor Truelove Witts yang memiliki sensitivitas dan spesifi sitas yang 
cukup tinggi untuk KU pada fase penyakit aktif. Interleukin-6 (IL-6) adalah sitokin pro-infl amasi yang berperan 
sangat penting pada mekanisme pertahanan diri dan berfungsi sebagai protein fase akut. Kadar serum IL-6 dan 
peningkatan ekspresinya pada mukosa kolon pasien IBD aktif menunjukkan tingkat aktivitas penyakit IBD.
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Introduction 
Infl ammatory Bowel Disease (IBD) is a 
chronic infl ammatory disease that involves the 
gastrointestinal tract, is remission and relapse 
with the exact cause so far not known clearly. 
Broadly speaking IBD consists of ulcerative 
colitis (UC), Crohn's disease (PC) and when 
it is diffi  cult to distinguish both, it is included 
in the category of indeterminate colitis.1
Based on international statistics, IBD 
incidence is around 2.2-14.3 cases per 100.000 
people per year for UC and 3.1 to 14.6 cases per 
100.000 people per year for Crohn disease.2Th e 
incidence of ulcerative colitis in the United States 
is about 15 per 100.000 people respectively and 
remains constant. This prevalence estimated 
at 200 per 100.000 population.3 Th ere are no 
epidemiological study of IBD1 for UC incidence 
at Sardjito General Hospital in 2014 from 
medical record obtained 35 inpatients and 14 
outpatients (Sardjito General Hospital medical 
records data, 2014).
Ulcerative colitis just like Crohn's disease 
has phases in the course of the illness that is 
the active phase or remission. In the active 
phase, there is a decrease in oral nutrition 
intake due to abdominal pain and anorexia. 
Infl ammatory bowel mucosa may accompanied 
by diarrhea causing loss of protein, blood, 
minerals, electrolytes and various elements 
and nutrient mal-absorption. As a result, 
in this active phase patients are at risk for 
malnutrition.4 Assessment of this degree 
of severity especially in the active phase is 
important, as it will determine treatment 
considerations, counseling and prognosis in 
IBD patients.5
Practices for assessing the degree of 
severity associated with the ulcerative colitis 
phase can be used in various traps, including 
Truelove Witts score, Mayo score and the 
classifi cation of Montreal.6,7 
Th e Truelove Witts classifi cation is one 
of the criteria that assess the degree of UC 
clinic based on frequency of diarrhea, presence/ 
absence of fever, degree of severity of anemia 
and rate of sedimentation or C-reactive protein 
(CRP).
The Truelove Witts classification 
compared to the Mayo and Montreal criteria 
Tujuan Penelitian. Untuk mengetahui hubungan antara ekspresi IL-6 dengan keparahan penyakit KU 
menggunakan klasifi kasi Truelove Witts.
Metode. Penelitian ini menggunakan metode cross sectional yang menganalisa hubungan antara ekspresi IL-6 
dengan beratnya KU berdasarkan klasifi kasi Truelove Witts menggunakan hasil pemeriksaan biopsi jaringan 
kolon dari pasien KU yang memenuhi kriteria inklusi dan eksklusi.
Hasil Penelitian. Sebanyak 26 subyek penelitian diteliti dan dilakukan analisa secara endoskopi serta patologi 
anatomi. Rerata usia subyek penalitian 52,73+11,11 tahun dengan subyek terbayak pria (n=15). Subyek dengan 
severitas KU 16 (61,5%), sedang 7 (26,9%) dan berat 3 (11,5%). Lebih banyak subyek pria pada KU derajat 
ringan 12 vs. 3 dan lebih banyak subyek wanita pada KU derajat sedang-berat 4 vs. 7 (p 0,032). Perbedaan 
bermakna pada kriteria BAB > 4 kali/hari, kadar IL-6 300 (285-400) berbanding dengan BAB < 4 kali/hari, 
IL-6 295 (212,1-340) p 0,039. Perbedaan bermakna ekspresi IL-6 antara KU derajat ringan 295 (212,1-340) 
dengan KU derajat sedang-berat 301,66 (235,57-400) dengan nilai p 0,032.
Kesimpulan. Ekspresi IL-6 pada subyek KU derajat sedang-berat lebih tinggi dibandingkan dengan KU derajat 
ringan berdasarkan kriteria Truelove Witts.
Kata kunci: Infl amatory Bowel Disease, kolitis ulseratif, klasifi kasi Truelove Witts, Interleukin-6.
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has considerable sensitivity and specifi city for in 
the active disease phase7. UC patients have an 
activated immune response, both the congenital 
immune system (macrophages, neutrophils) 
and the acquired immune (T cells and B cells), 
which lose tolerance to commensal bacteria in 
the intestinal mucosa. In the immune system, 
T cells play an important role in regulating the 
proliferation and diff erentiation of B cells into 
antibody-producing cells.
Further research by purification and 
cloning showed that BSF-2 consisted of 184 
amino acids weighing 26 kDa, which based 
on agreement fi nally named interleukin 68. 
Interleukin 6 is a more prominent mediator 
than other cytokines for the systemic response 
of a localized infl ammation. Interleukin 6 is a 
pro-infl ammatory cytokine that plays a very 
important role in self-defense mechanism and 
acts as an acute phase protein that induces the 
diff erentiation of B cells and T cells so that 
it can be an indicator for the assessment of 
the diseases of UC9 disease. Levels of serum 
interleukin 6 and increased expression in 
colonic mucosa of active IBD patients indicate 
the level of IBD10 disease activity.
Th e purpose of this study was to determine 
the relationship between IL-6 expression and 
the severity of UC disease using Truelove Witts 
classifi cation.
Methods
Th e subjects of this study were patients 
aged over 18 years who declared ulcerative 
colitis based on endoscopy results between 
December 2016 and July 2017 at Dr. Sardjito 
Hospital, PKU Muhammadiyah Bantul 
Hospital and willing to follow the research by 
signed informed consent. Exclusion criteria of 
this study were patients who did not experience 
the disease of colorectal malignancy.
Th e gastro-entero hepatology polyclinic 
patients and Dr. Sardjito General Hospital 
ward that fulfi ll the inclusion and exclusion 
criteria got an explanation of the research. 
Patient data record included complaint 
manifestation of ulcerative colitis (frequency 
of diarrhea with or without blood), vital signs 
(blood pressure, pulse, and respiratory rate and 
body temperature), age, sex, weight, height, 
BMI. Patients also have taken blood samples 
to obtain Hb and LED values. Data obtained 
from the history, physical examination and 
laboratory examination were recorded in the 
study form. Degree classifi cation of Truelove 
Witts, interleukin 6 expressions and statistical 
analysis were assesed.
Statistical Analysis
Independent variables were the degree 
of severity of ulcerative colitis used the 
Truelove Witts classifi cation and dependent 
variables were IL-6 tissue expression based on 
immunohistochemistry. Univariate analysis 
of basic characteristic data was processed and 
exposed by descriptive method in mean ± 
standard deviation (SD), median or number 
(%) based on existed variables and categorical in 
terms of number and percentage. To determine 
the relationship between IL-6 expression and 
degree of ulcerative colitis by Truelove Witts 
classifi cation was excluded by Kruskall Wallis 
test, which was confi rmed by Mann Whitney 
test. Th e data was processed using the IBM 
Statistical Product and Service Solutions 
(SPSS) version 22-computer program. Th e 
p value <0.05 was considered statistically 
signifi cant. 
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Results
In this study, 27 research subjects checked 
into polyclinic in Dr. Sardjito General Hospital 
and PKU Muhammadiyah Bantul Hospital. 
After done the colonoscopy, a macroscopic 
ulcerative colitis image was confi rmed by biopsy 
examination. Th e 27 subjects were studied by 
data analysis and passed the assessment the 
severity of ulcerative colitis based on Truelove 
Witts criteria (mild, moderate and severe). 
Th e mean age of the study subjects was 
52.73+11.11 years with 15 subjects were men 
(57.7%). Most subjects did not smoke 21 
subjects (80.8%), average body mass index of 
22.18+4.97 kg / m2. Mean of hemoglobin level 
12.77+1.71 g / dl; leukocyte 8.22+2.86 103/
mm3 and ESR 21.26 (4-63) mm/h. UC mild 
degree was obtained in 16 subjects (61.5%), 
moderate degree in 7 subjects (26.9%) and 
degree of weight in 3 subjects (11.5%). Th e 
median value of interleukin 6 in this study was 
297.55 with the lowest score 212.1 and the 
highest value 400. Th e severity level of UC in 
male subjects was the highest with mild degree 
13 subjects (81.25%) and moderate-severe 
3 subjects (18.75%). The women subjects 
weighing 7 subjects (63.67%) and mild degree 
lightness 4 subjects (36.33%) with p value 
0.032. While age, BMI, smoking status and 
Salofak therapy did not signifi cantly diff erent.
Discussion
Th e signifi cant diff erences were seen in 
the defecation criteria> 4 times/day where the 
IL-6 300 (285-400) levels were compared with 
defecation <4 times/day, IL-6 295 (212.1-340) 
p 0.039. Other criteria components such as 
pulse frequency, body temperature, Hb, ESR 
and CRP levels found no signifi cant diff erences. 
Based on table 4, we found that IL-6 levels 
were based on Truelove Witts criterion were 
295 (212.1-340) for mild severity and 301.66 
(235.57-400) for moderate-severe with a 
p value of 0.032, meaning that there was a 
signifi cant diff erence between the severity mild 
to moderate-severe ulcerative colitis.
In this study obtained the subject of 15 
male and 11 female. Epidemiologically, the 
incidence of ulcerative colitis in males and 
females found no signifi cant diff erence with 
5.7 point. Th e mean age of the entire study 
subjects was 52.73+11.11 years. According 
to research in the United Kingdom, UC 5 
disease can aff ect any age but tend to be higher 
in the third or fourth decade.5 In Indonesia, 
this epidemiological study has not yet been 
explored. Based on body mass index, the 
subject of study has not included the category 
of malnutrition. Underweight and nutrient 
status were commonly found in patients with 
Crohn disease and its lower in ulcerative colitis. 
One study suggested that body mass index was 
higher in ulcerative colitis (25.2 kg/m2) than 
Chron disease (22.8 kg/m2) 11.
UC patients
inclusion criteria
UC patients in RSUP Dr. Sardjito
UC severity based on 
Truelove Witts criteria
exclusion criteria
research sample (biopsy and 
endoscopy)
IHC staining with IL-6 antibody
result analysis
Figure 1. Research fl ow
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In this study obtained the number of 
subjects only as many as 27 subjects. Although 
theoretically, ulcerative colitis may occur at 
any age, but the larger number of subjects 
according to the sample calculations will 
further refi ne the results of the study. Another 
limitation of the study is 5-ASA therapy in 
subjects may decrease the expression of IL-6 
in the mucosa due to the anti-infl ammatory 
potential of the drug.
Research limitations
Th is study conducted to determine the 
criteria using only restriction medical records. 
Th e subjects of the study were 110 subjects, 
but only 91 subjects joined the study because 
of the visibility time. To ensure the routinely of 
PLB does the research, in addition to assist the 
patient’s family also made regular home visits to 
the randomized subjects. However constraints 
to the distance some regular visits replaced by 
telephone contact.
Conclusion
Th e expression of IL-6 mucosal colonic 
tissue were higher on moderate-severe ulcerative 
colitis according to Truelove Witts criteria with 
p 0.032. Suggestion to the further study, might 
be continued with a larger sample size in each 
degree of ulcerative colitis.
Table 1. Baseline Characteristic
Baseline Characteristic n (%) Mean+SB / Media (min-max)
Age 52.73+11.11
Sex
Men 15 (57.7)
Women 11 (42.3)
Smoking Status
Non-smoker 21 (80.8)
Active smoker 1 (3.8)
Ex-smoker 4 (15.4)
BMI (kg/m2) 22.18+4.97
Hemoglobin (g/dl) 12.77+1.71
Leukocyte (103/mm3) 8.22+2.86
ESR (mm/hour) 21.26 (4-63)
Severity
Mild 16 (61.5)
Moderate 7 (26.9)
Severe 3 (11.5)
Salofalk routine 9 (34.6)
Interleukin-6 297.55 (212.1-400)
Table 2 Baseline characteristic based on UC severity by Truelove Witts 
criteria UC Severity
Variable Mild 16 (61.5%)n (%)
Moderate-severe 10
(38.5%) n (%) p Value
Sex
Men 12 (80) 3 (20) 0.032a
Women 4 (36.4) 7 (63.6)
Age (years) (mean+SB) 49.62+12.2 57.7+7.1 0.070b
BMI (kg/m2) (mean+SB) 22.14+4.64 22.25+5.73 0.956b
Smoking Status
Ex-Smoker 2 (50) 2 (50) 0.653c
Active smoker 1 (100) 0
Non-smoker 13 (61.9) 8 (38)
Salofalk routine 7 (77.8) 2 (22.2) 0.210a
aFisher exact test; bNon-paired t test; cChi-square test
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